A Federal Consistency Certification has been submitted to the Delaware Coastal Management Program for the following: STA Pharmaceutical Plant Middletown (2022.0061)

STA Pharmaceutical proposes to construct a new pharmaceutical manufacturing campus in Middletown, Delaware. The 190-acre new facility will feature space for testing laboratories; manufacture of active pharmaceutical ingredients (APIs); and manufacture and packaging of solid dosage pharmaceutical products and sterile products.

Comments concerning this Federal Consistency Certification will be accepted for 30 days from the date of this notice. Comments may be sent to: Delaware Coastal Programs, Ms. Kimberly Cole, Administrator, 100 W. Water Street, Suite 7B, Dover, DE, 19904, or electronically to DNREC_DCP_PublicComment@delaware.gov. For additional information please call (302) 739-9283.

Related Topics:  climate coastal energy, coastal programs, dcmp, federal consistency, permitting and regulation, pharmaceutical manufacturing, public notice